Porzio Welcomes Litigation Attorney Martin J. Healy
MORRISTOWN, N.J. – Porzio, a leading national law firm, is pleased to announce the arrival of Martin J. Healy as a principal to its Litigation Practice Group. Mr. Healy joins the firm from Sedgwick, LLP where he was a partner. He brings with him 25 years of litigation experience, including class actions and multi-district litigation, in state and federal courts across the country.
"Marty is a highly regarded litigator in the region, having handled thousands of cases in numerous jurisdictions with great success, including numerous jury trials. We are confident he will be a tremendous asset to our litigation practice, further enhancing our capabilities to provide valuable counsel for our clients' litigation, business and compliance needs," said Vito A. Gagliardi, Jr., managing principal of the firm.
Mr. Healy represents pharmaceutical, medical device, engineering, and product manufacturing clients in a variety of ways, ranging from corporate compliance to product liability, to consumer fraud and toxic tort actions. He also has a strong background in data management, data privacy and cybersecurity, counseling clients on risk avoidance, risk management and regulatory compliance.
Mr. Healy's industry experience in drug and medical device also complements Porzio Life Sciences (PorzioLS), the firm's subsidiary. PorzioLS helps companies in the life sciences industry improve their sales and marketing programs' productivity and efficiency while maintaining compliance with complex federal and state regulations.
"I am excited to be a part of a firm with such a distinctive entrepreneurial culture," said Mr. Healy. "Our combined reputation in life sciences, litigation and regulatory compliance creates an environment where collaboration and client service will lead to success."
A graduate of Villanova University and The John Marshall School of Law, Mr. Healy has been recognized as "AV Preeminent" by Martindale Hubbell in the fields of Product Liability, Litigation and Torts. He is admitted in New Jersey, New York and Pennsylvania.